Homemade Vaccine Beer: Scientific Breakthrough or Madness?

A National Cancer Institute virologist home-brewed a genetically engineered beer as an unsanctioned vaccine, testing it on himself and family—bypassing federal regulations in a move that alarms conservatives wary of government overreach in science.

Story Highlights

Chris Buck engineered yeast to produce polyomavirus vaccine particles in Lithuanian-style ale, targeting BK virus linked to cancers in transplant patients.
Buck drank the beer himself starting late May 2025, with family testers reporting antibodies but no peer review or institutional approval.
Public recipe release on Zenodo.org invites DIY replication, raising safety risks and challenging NIH ethics restrictions.
Promises cheap, needle-free vaccines for low-resource areas but sparks controversy over untested self-experimentation.
Experts praise gut immunity potential while cautioning on unknown long-term effects and lack of clinical trials.

Buck’s DIY Vaccine Breakthrough

Chris Buck, a virologist at the National Cancer Institute in Maryland, developed genetically engineered brewer’s yeast to produce virus-like particles targeting BK polyomavirus. This virus reactivates in immunocompromised patients, causing kidney rejection in transplants, bladder cancers, and brain issues. Over 15 years, Buck’s NCI team advanced injectable VP1 protein vaccines tested in animals and licensed in India. Mouse tests confirmed oral live yeast beer induced antibodies, surviving stomach acid for gut immunity. Buck separated home-brewing from NCI due to ethics bans on self-testing, using his nonprofit Gusteau Research Corporation.

Self-Experimentation Timeline and Testing

Buck drank the first pint daily for five days in late May 2025, followed by boosters seven weeks later. His brother Andrew co-tested, and both posted antibody data plus the full recipe on Zenodo.org on December 17, 2025, via Buck’s Substack “Viruses Must Die.” Early 2026 saw Buck present at the World Vaccine Congress in Washington, calling results an “earthquake” for open-access science. Family reported safe antibody levels against BK subtypes II and IV with no adverse effects. This marks the first human self-experiment with home-brewed yeast-based oral vaccine, distinct from prior yeast vaccines like hepatitis B.

Ethical and Regulatory Concerns Emerge

The work lacks peer review, large-scale human trials, or oversight, drawing criticism for blurring personal and professional lines with family testers. NCI remains uninvolved in the beer phase due to NIH prohibitions. Experts like immunologist Bart Chackerian from University of New Mexico call live yeast gut delivery “exciting” for other diseases. Critics stress antibodies do not guarantee protection, with unknown side effects. Historical self-experiments like Barry Marshall’s H. pylori ingestion succeeded but modern bioethics demands controls, highlighting tensions between innovation and safety in federally funded research.

Potential Impacts on Health and Industry

Short-term, the project fuels debates on self-experimentation ethics and accelerates oral vaccine research. Long-term, validated food-vaccine hybrids could disrupt pharma with low-cost, needle-free production for global access, leveraging fermentation in low-resource areas. Transplant patients and immunocompromised stand to benefit from BK protections. Breweries express wariness over “vaccine beer” branding. Socially, palatable beer form may build trust among vaccine-hesitant, but risks misuse by homebrewers. Politically, it challenges regulations favoring individual liberty and open science over bureaucratic hurdles.

This cancer researcher home-brewed a beer that works as a vaccine. And he's publishing the process so you can do it too. https://t.co/dJyiqjJlep

— reason (@reason) March 15, 2026

Conservative Perspective on Open Science

Under President Trump’s administration, emphasizing limited government, Buck’s initiative aligns with conservative values of personal responsibility and innovation free from overregulation. Past leftist policies stifled such breakthroughs through endless red tape, mirroring frustrations with globalist vaccine mandates. While risks exist without trials, public recipe sharing empowers individuals, much like Second Amendment self-defense. Transplant patients gain hope against cancers tied to unchecked viruses, underscoring common-sense priorities over institutional gatekeeping. Limited human data tempers enthusiasm, but mouse successes warrant further exploration.